Vital Images hits advanced visualization sales milestone

TriMed Staff | | Health Imaging | Artificial Intelligence
Vital Images has surpassed the milestone of 3,000 customers and approximately 5,000 installations of advanced visualization software solutions. 

“We are very proud of reaching this customer milestone and committed to continued delivery of advanced visualization solutions and collaboration tools that can be quickly and easily integrated into daily medical practice,” said Michael H. Carrel, president and CEO, Vital Images. “We have strong, collaborative relationships with our customers based on the common goal of enterprise-wide access of advanced visualization solutions designed to improve the impact and delivery of patient care.”

TriMed Staff

Related Content

Mayo Clinic and Microsoft partner to advance generative AI in radiology
ACR partners to create AI foundational model assessment website
Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.